tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Innovent Biologics (HK:1801)
:1801
Hong Kong Market
1801
Innovent Biologics
RESEARCH TOOLSreports

Innovent Biologics (1801) Stock News & Sentiment

Compare
21 Followers
Innovent Biologics’ Seven Drugs Added to China’s National Reimbursement List
Premium
Company Announcements
Innovent Biologics’ Seven Drugs Added to China’s National Reimbursement List
8d ago
Innovent Biologics Grants Share Options to Boost Employee Engagement
Premium
Company Announcements
Innovent Biologics Grants Share Options to Boost Employee Engagement
10d ago
Innovent Biologics Closes Strategic Partnership with Takeda
Premium
Company Announcements
Innovent Biologics Closes Strategic Partnership with Takeda
11d ago
Innovent Biologics’ PECONDLE® Approved for Psoriasis Treatment in China
Premium
Company Announcements
Innovent Biologics’ PECONDLE® Approved for Psoriasis Treatment in China
17d ago
Innovent’s Mazdutide 9mg Application Accepted by China’s NMPA
Premium
Company Announcements
Innovent’s Mazdutide 9mg Application Accepted by China’s NMPA
20d ago
Innovent Biologics Achieves 40% Revenue Growth in Q3 2025
Premium
Company Announcements
Innovent Biologics Achieves 40% Revenue Growth in Q3 2025
2M ago
Innovent Biologics and Takeda Partnership Fuels Global Expansion and Strengthens Buy Rating
Premium
Ratings
Innovent Biologics and Takeda Partnership Fuels Global Expansion and Strengthens Buy Rating
2M ago
More HK:1801 News >

1801 News on the Web

Innovent Biologics’ Seven Drugs Added to China’s National Reimbursement List
TipRanks News
Neutral
Innovent’s Mazdutide 9mg Application Accepted by China’s NMPA
TipRanks News
Neutral
Innovent Biologics' Mazdutide Phase 3 Trial In Obesity Achieves Primary & Key Secondary Endpoints
rttnews
Neutral
Innovent Biologics' Mazdutide Surpasses Semaglutide In HbA1c And Weight Loss In Phase 3 Trial
rttnews
Neutral
Takeda And Innovent Biologics Sign Global Oncology Collaboration Outside Greater China
rttnews
Neutral
Innovent Biologics (IVBXF) Receives a Buy from J.P. Morgan
TipRanks News
Neutral
Goldman Sachs Reaffirms Their Buy Rating on Innovent Biologics (IVBXF)
TipRanks News
Neutral
Innovent Biologics Completes HK$4.27 Billion Share Placement
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:1801’s Media Buzz Sentiment?
Currently, no data Available
What is HK:1801’s weekly average amount of articles?
Currently, no data Available
What is HK:1801’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
XCURExicure
SCLPScancell Holdings
STAAStaar Surgical
WSTWest Pharmaceutical Services
CVSCVS Health
Showing the stocks with the most bullish news sentiment over the past week